medigraphic.com
Revista Médica Sinergia

2020, Number 10

<< Back Next >>

Revista Médica Sinergia 2020; 5 (10)

Contrast-induced acute kidney injury

Arias LML, Ramírez VX, Madrigal ZS

Language: Spanish
References: 16
Page: 1-12
PDF size: 193.57 Kb.


ABSTRACT

Acute kidney injury can be defined by various criteria, such as an increase in serum creatinine 1.5 times over the reference value after the use of contrast media. Contrast media are solutes of different osmolalities, which are used to perform various medical procedures. The incidence of this disease frequently varies from various factors, such as factors specific to each patient, dose of contrast medium, route of administration of the contrast, among others. The pathophysiological mechanisms involved in acute kidney injury are multifactorial and have not yet been fully identified, therefore, it is important to perform a good medical history and physical examination to identify this population at risk and case measures such as nephroprotection. In turn, it is important for all doctors to know the potentially nephrotoxic drugs and their proper management with patients at risk, since once the contrastinduced nephropathy is established, there is no effective treatment and patients can progress to various difficulties, worsening the prognosis. in the short and long term.


REFERENCES

  1. Kidney International suplemments. KDIGO Clinical Practice Guideline for Acute Kidney Injury. [internet] 2012 (2) 69-88. https://doi.org/10.1038/kisup.2011.34

  2. Mehran R, D. Dangas G, D. Weisbord S. Contrast-Associated Acute Kidney Injury. The New England Journal of Medicine. [internet] 2019 (22) 2146-2155. https://doi.org/10.1056/NEJMra1805256

  3. Bastida-Alquicira J, Motta-Ramírez G, Amezquita-Pérez S, Gómez-Vázquez J, Donde el arte y la ciencia se unen: la nefropatía inducida por medio de contraste y sus factores de riesgo asociados. Med Int Méx. [internet] 2015 (31) 64-76. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim- 2015/mim151j.pdf

  4. Ferreira Morales J. Actualidad en nefropatía por medio de contraste. Elsevier [internet] 2017 (2) 69-78. https://doi.org/10.1016/j.nefrol.2017.03.001

  5. Mamoulakis C, Tsarouhas K, Fragkiadoulaki I, Heretis I, F. Wilks M, A. Spandidos D, Tsitsimpikou C, Tsatsakis A, Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Elsevier. [internet] 2017 (180) 99-112. https://doi.org/10.1016/j.pharmthera.2017.06.009

  6. Shu Min T, L. Wichmann J,Schoep J, R. Fuller S, Ming Lu G, Jiang Zhang L. Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention. Eur Radiol. [internet] 2015 (1) 1-9. https://doi.org/10.1007/s00330-015-4155-8

  7. C. Chyou A, Thodge A, N. Feldman D, V. Swaminathan R. Statins in the Prevention of Contrast-Induced Nephropathy. Curr Treat Options Cardio Med. [internet] 2015 (15) 1-12. https://doi.org/10.1007/s11936- 015-0375-0

  8. Wichmann J, Katzberg R, Litwin S, Zwerner P, De Cecco C, Vogl T, Costello P, Schoepf J. Contrast-Induced Nephropathy. AHA Journals. [internet] 2015 (20) 1931-1936. https://doi.org/10.1161/CIRCULATIONAHA.115.014672

  9. Silver S, Shah P, Chertow G, Harel S, Wald R , Harel Z. Risk Prediction Models for Contrast Induced Nephropathy: Systematic Review. Pubmed. [internet]. 2015 (27) 43-95. https://doi.org/10.1136/bmj.h4395

  10. Castelo Villalón X, Borges Moreno Y, Guevara Mirabal G, Martínez Carrillo A, Hechavarría Pouymiro S, García Romero J, Nefropatía inducida por contraste en la cardiología intervencionista. Revista Cubana de Cardiología y Cirugía Cardiovascular. [internet] 2017 (23) 1561-2937. Disponible en: http://www.revcardiologia.sld.cu/index.php/revcardiologia/article/view/703

  11. Fang Ho Y, Hsieh K,Kung F, Lin WU F,Hsieh L,Chou H, Chen S. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT. AJR. [internet] 2015 (205)703-708. https://doi.org/10.2214/AJR.15.14329

  12. Hernando L, Canovas E, Freites A, De La Rosa A, Alonso J, Del Castillo R, Salinas P, Montalvo G, Huelmos, Botas MJ. Prevalencia y pronóstico de la nefropatía tras intervencionismo coronario percutáneo de pacientes con síndrome coronario agudo y función renal normal. Rev Esp Cardiol. [internet] 2015 (4):310- 316. https://doi.org/10.1016/j.recesp.2014.04.018

  13. Davenport M, R Cohan,Ellis J. Contrast Media Controversiesin 2015: Imaging Patients With Renal Impairment or Risk of Contrast Reaction. American Roentgen Ray Society. [internet] 2015 (204) 1174- 1181. https://doi.org/10.2214/AJR.14.14259

  14. Fernandez Cimadevilla O, Barriales-Alvarez V, Martínez Luengas I. Nefropatía inducida por contraste. Elsevier. [internet] 2011;137 (2):84-90. https://doi.org/10.1016/j.medcli.2010.04.008

  15. Nunes Filho A, Katz M, Campos C, Carvalho L, Siqueira D, Tumelero R, Portella A, Esteves V, Perin M, Sarmento-Leite R,Lemos Neto P, Tarasoutchi F, Bezerra H, De Brito F. Impacto del daño renal agudo en el seguimiento a corto y a largo plazo tras el implante percutáneo de válvula aortica. Rev Esp Cardiol. [internet]. 2019;72(1):21-29. https://doi.org/10.1016/j.recesp.2017.11.018

  16. Yildirim E, Turer Cabbar A. Association between copeptin and contrast-induced nephropathy in patients with ST-elevation myocardial infarction. Rev Port Cardiol. [internet]. 2019;38(12):873-879. https://doi.org/10.1016/j.repc.2019.06.005




2020     |     www.medigraphic.com